经皮冠状动脉血运重建术中“微小心肌梗死灶”的神话。 - Suppr

Suppr

超能文献

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures.

作者信息

Abdelmeguid A E, Topol E J

机构信息

Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA.

出版信息

Circulation. 1996 Dec 15;94(12):3369-75. doi: 10.1161/01.cir.94.12.3369.

DOI:10.1161/01.cir.94.12.3369

PMID:8989153

Abstract

摘要

相似文献

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures.经皮冠状动脉血运重建术中“微小心肌梗死灶”的神话。

Circulation. 1996 Dec 15;94(12):3369-75. doi: 10.1161/01.cir.94.12.3369.

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

J Am Coll Cardiol. 1995 Jun;25(7):1693-9. doi: 10.1016/0735-1097(95)00091-h.

Prognostic implications of cardiac marker elevation after percutaneous coronary intervention.经皮冠状动脉介入治疗后心脏标志物升高的预后意义。

Circulation. 2002 Mar 26;105(12):e73. doi: 10.1161/01.cir.0000012245.51323.59.

Emergency surgical revascularization following coronary angioplasty: evaluation of operative results by isoenzyme analysis and electrocardiography.冠状动脉成形术后的急诊手术血运重建：通过同工酶分析和心电图评估手术结果

Eur J Cardiothorac Surg. 1989;3(6):549-53. doi: 10.1016/1010-7940(89)90117-6.

Significance of creatine kinase release after coronary interventions.冠状动脉介入术后肌酸激酶释放的意义。

Catheter Cardiovasc Interv. 1999 Oct;48(2):130-2. doi: 10.1002/(sici)1522-726x(199910)48:2<130::aid-ccd2>3.0.co;2-t.

Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure.短暂性、无并发症的实验室冠状动脉闭塞的长期预后。

Circulation. 1995 Jun 1;91(11):2733-41. doi: 10.1161/01.cir.91.11.2733.

[Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions].经皮冠状动脉血运重建干预后心肌损伤指标升高的预后意义

Ital Heart J Suppl. 2002 Mar;3(3):286-96.

Clinical implications of the new definition of myocardial infarction.心肌梗死新定义的临床意义。

Heart. 2004 Jan;90(1):99-106. doi: 10.1136/heart.90.1.99.

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.

Circulation. 1996 Oct 1;94(7):1528-36. doi: 10.1161/01.cir.94.7.1528.

Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality.经皮冠状动脉介入治疗后的心肌酶升高：心肌坏死、冠状动脉微循环与死亡率

J Am Coll Cardiol. 2000 Apr;35(5):1142-4. doi: 10.1016/s0735-1097(00)00524-6.

引用本文的文献

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.围手术期心肌梗死的定义及其与一年死亡率的关系：来自 CHAMPION 试验的观察。

Int J Cardiol. 2018 Nov 1;270:96-101. doi: 10.1016/j.ijcard.2018.06.034. Epub 2018 Jun 8.

Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center.在 VU 大学医学中心的日常实践中，对存在冠状动脉狭窄且测量出的血流储备分数（FFR）≥0.75 的患者。

Neth Heart J. 2010 Sep;18(9):402-7. doi: 10.1007/BF03091806.

Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after percutaneous coronary intervention.经皮冠状动脉介入治疗后循环中 P-选择素、纤溶酶原激活物抑制剂-1、镁和肌酸激酶的时间变化。

J Zhejiang Univ Sci B. 2010 Aug;11(8):575-82. doi: 10.1631/jzus.B1001006.

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.经皮冠状动脉介入治疗前钙通道阻滞剂治疗对肌酸激酶-MB水平的影响。

Vasc Health Risk Manag. 2008;4(6):1417-22. doi: 10.2147/vhrm.s2998.

The impact of surgical and percutaneous coronary revascularization on the cardiac myocyte.

World J Surg. 2008 Mar;32(3):361-5. doi: 10.1007/s00268-007-9366-y.

Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.阿司匹林治疗后血小板持续反应性对择期经皮冠状动脉介入治疗后心肌肌钙蛋白I和肌酸激酶同工酶MB水平的影响。

J Thromb Thrombolysis. 2008 Jun;25(3):239-46. doi: 10.1007/s11239-007-0067-z. Epub 2007 Jun 16.

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.经皮冠状动脉介入治疗后的临床终点定义及其与晚期死亡率的关系：归因风险评估

Heart. 2006 Jul;92(7):945-50. doi: 10.1136/hrt.2005.078758. Epub 2005 Dec 30.

Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.经皮冠状动脉介入治疗中血小板糖蛋白IIb/IIIa抑制剂：聚焦依替巴肽的药代动力学-药效学关系

Clin Pharmacokinet. 2003;42(8):703-20. doi: 10.2165/00003088-200342080-00001.

Coronary microembolization--its role in acute coronary syndromes and interventions.冠状动脉微栓塞——其在急性冠状动脉综合征及干预措施中的作用

Herz. 1999 Nov;24(7):558-75. doi: 10.1007/BF03044228.

Prevalence of microvascular disease in patients with significant coronary artery disease.严重冠状动脉疾病患者微血管疾病的患病率。

Herz. 1999 Nov;24(7):548-57. doi: 10.1007/BF03044227.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验